Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts

A Draft 'No' To Roche’s Lymphoma Contender

Executive Summary

Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.

You may also be interested in...



UK Biotechs Seek Government Help As Economic ‘Heart Attack’ Threatens Sector

Huge economic shock to sector could be quickly alleviated by early payment of R&D Tax Credits, says BIA.

Big Pharma Leaders Show United Front On COVID-19

Costs will be an issue, but not today; industry and healthcare systems are working at breakneck speed to catch up with the deadly virus.

Coronavirus Update: Synairgen Tests First Inhaled Candidate, No New China Cases

More studies are being launched into possible treatments for patients hospitalised with COVID-19, with Roche launching a Phase III, placebo-controlled trial of Actemra.

Topics

Related Companies

UsernamePublicRestriction

Register

SC141727

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel